275 related articles for article (PubMed ID: 37242663)
1. Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.
Leu JSL; Teoh JJX; Ling ALQ; Chong J; Loo YS; Mat Azmi ID; Zahid NI; Bose RJC; Madheswaran T
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242663
[TBL] [Abstract][Full Text] [Related]
2. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
Chountoulesi M; Pispas S; Tseti IK; Demetzos C
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
[TBL] [Abstract][Full Text] [Related]
3. Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds.
Tan C; Hosseini SF; Jafari SM
J Agric Food Chem; 2022 Feb; 70(5):1423-1437. PubMed ID: 35089018
[TBL] [Abstract][Full Text] [Related]
4. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
Zhai J; Fong C; Tran N; Drummond CJ
ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
[TBL] [Abstract][Full Text] [Related]
5. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.
Madheswaran T; Kandasamy M; Bose RJ; Karuppagounder V
Drug Discov Today; 2019 Jul; 24(7):1405-1412. PubMed ID: 31102731
[TBL] [Abstract][Full Text] [Related]
6. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles.
Yaghmur A; Mu H
Acta Pharm Sin B; 2021 Apr; 11(4):871-885. PubMed ID: 33996404
[TBL] [Abstract][Full Text] [Related]
8. Cell interactions with lipid nanoparticles possessing different internal nanostructures: Liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes.
Yap SL; Yu H; Li S; Drummond CJ; Conn CE; Tran N
J Colloid Interface Sci; 2024 Feb; 656():409-423. PubMed ID: 38000253
[TBL] [Abstract][Full Text] [Related]
9. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
10. Polymer Cubosomes: Infinite Cubic Mazes and Possibilities.
Ha S; La Y; Kim KT
Acc Chem Res; 2020 Mar; 53(3):620-631. PubMed ID: 31920073
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic and Dynamic Heterogeneity of Nonlamellar Lyotropic Liquid Crystalline Nanodispersions.
Yaghmur A; Moghimi SM
ACS Nano; 2023 Nov; 17(22):22183-22195. PubMed ID: 37943319
[TBL] [Abstract][Full Text] [Related]
12. Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation.
Badie H; Abbas H
Drug Dev Ind Pharm; 2018 Dec; 44(12):2013-2025. PubMed ID: 30095009
[TBL] [Abstract][Full Text] [Related]
13. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
[TBL] [Abstract][Full Text] [Related]
14. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
[TBL] [Abstract][Full Text] [Related]
15. Hexosomes: a novel drug delivery system.
Hirlekar R; Jain S; Patel M; Garse H; Kadam V
Curr Drug Deliv; 2010 Jan; 7(1):28-35. PubMed ID: 20044910
[TBL] [Abstract][Full Text] [Related]
16. Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.
Rajesh S; Zhai J; Drummond CJ; Tran N
J Colloid Interface Sci; 2021 May; 589():85-95. PubMed ID: 33450463
[TBL] [Abstract][Full Text] [Related]
17. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L
Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230
[TBL] [Abstract][Full Text] [Related]
18. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
Singh S; Sachan K; Verma S; Singh N; Singh PK
Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
[TBL] [Abstract][Full Text] [Related]
19. Cubosomes and hexosomes as versatile platforms for drug delivery.
Azmi ID; Moghimi SM; Yaghmur A
Ther Deliv; 2015; 6(12):1347-64. PubMed ID: 26652281
[TBL] [Abstract][Full Text] [Related]
20. Cubosomes: The Next Generation of Smart Lipid Nanoparticles?
Barriga HMG; Holme MN; Stevens MM
Angew Chem Int Ed Engl; 2019 Mar; 58(10):2958-2978. PubMed ID: 29926520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
